Bone Health and Fracture Prevention for Orthopedic Referrals - Summary - MDSpire

Bone Health and Fracture Prevention for Orthopedic Referrals

Baptist Health Orthopedic Care offers a Bone Health and Fracture Prevention Program for patients at increased risk of fracture who may benefit from early evaluation and treatment.

  • April 16, 2026

  • 2 min

Share

Objective:

To provide a structured program for early identification and management of patients at increased risk of fractures.

Approach:
    Key Findings:
    • Multidisciplinary care can significantly reduce fracture risk.
    • Early evaluation and treatment are crucial for patients at risk.
    • Specialized care is available across multiple locations in South Florida.
    Interpretation:

    The program aims to identify and manage patients at risk for fractures effectively, enhancing bone health through specialized care.

    Limitations:
    • Limited to patients over age 50 or those with specific risk factors.
    • Geographically restricted to South Florida locations.
    Conclusion:

    The Bone Health and Fracture Prevention Program provides essential support for at-risk patients, promoting early intervention and specialized care.

    Sources:

Original Source(s)

Bone Health and Fracture Prevention for Orthopedic Referrals

  • April 16, 2026

Related Content

Low-Magnitude High-Frequency Vibration in Periodontal and Implant Therapy

Published data and case presentations document accelerated healing, improved osseous architecture, and greater functional stability.

Advanced Shoulder Replacement for Orthopedic Referrals Natural-motion design. Bone-preserving technique. Advanced care for patients limited by shoulder pain.

Baptist Health Orthopedic Care offers an advanced shoulder replacement designed for patients seeking a more personalized surgical solution for shoulder pain and loss of function.

  • April 13, 2026

  • 2 min
RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.